It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Single ribonucleoside monophosphates (rNMPs) are transiently present in eukaryotic genomes. The RNase H2-dependent ribonucleotide excision repair (RER) pathway ensures error-free rNMP removal. In some pathological conditions, rNMP removal is impaired. If these rNMPs hydrolyze during, or prior to, S phase, toxic single-ended double-strand breaks (seDSBs) can occur upon an encounter with replication forks. How such rNMP-derived seDSB lesions are repaired is unclear. We expressed a cell cycle phase restricted allele of RNase H2 to nick at rNMPs in S phase and study their repair. Although Top1 is dispensable, the RAD52 epistasis group and Rtt101Mms1-Mms22 dependent ubiquitylation of histone H3 become essential for rNMP-derived lesion tolerance. Consistently, loss of Rtt101Mms1-Mms22 combined with RNase H2 dysfunction leads to compromised cellular fitness. We refer to this repair pathway as nick lesion repair (NLR). The NLR genetic network may have important implications in the context of human pathologies.
RNase H2 removes mutagenic rNMPs from genomic DNA. The authors demonstrate how nicked rNMPs are repaired when they are encountered in S phase. This study unveils genetic interactions that could potentially be exploited in RNase H2-deficient pathologies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Johannes Gutenberg University Mainz, Institute for Developmental Neurology (IDN), Biozentrum 1, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111)
2 Institute of Molecular Biology (IMB), Mainz, Germany (GRID:grid.424631.6) (ISNI:0000 0004 1794 1771); New York University, Department of Biology, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
3 Institute of Molecular Biology (IMB), Mainz, Germany (GRID:grid.424631.6) (ISNI:0000 0004 1794 1771)
4 Johannes Gutenberg University Mainz, Institute for Developmental Neurology (IDN), Biozentrum 1, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111); Institute of Molecular Biology (IMB), Mainz, Germany (GRID:grid.424631.6) (ISNI:0000 0004 1794 1771)